Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A

Ana Barreira-Díaz1, Mar Riveiro-Barciela2, Eva María Fernández-Bonilla3

  • 1Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Liver Unit, Hospital Universitario Vall de Hebrón, Barcelona, Spain.

Annals of Hepatology
|February 25, 2024
PubMed
Summary

SARS-CoV-2 vaccine-induced liver injury is typically immune-mediated and heterogeneous. While re-exposure via boosters can cause frequent relapses, these are usually mild, and immunosuppression may reduce risk.